Translating in vitro mechanistic findings to in vivo toxicity outcomes: A case study of Usnic acid hepatotoxicity
Authors:
Open Access
- 20 April 2026
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 512, 117832
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration
This publication has 30 references indexed in Scilit:
- Oxidative DNA damage contributes to usnic acid‐induced toxicity in human induced pluripotent stem cell‐derived hepatocytesJournal of Applied Toxicology, 2024
- Quantitative in vitro to in vivo extrapolation of genotoxicity data provides protective estimates of in vivo doseEnvironmental and Molecular Mutagenesis, 2022
- Quantitative in vitro to in vivo extrapolation for developmental toxicity potency of valproic acid analoguesBirth Defects Research, 2022
- Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case StudiesClinical Pharmacokinetics, 2019
- Simultaneous determination of tilianin and its metabolites in mice using ultra‐high‐performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic studyBiomedical Chromatography, 2017
- A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell linesCell Biology and Toxicology, 2017
- Activation of the Nrf2 signaling pathway in usnic acid-induced toxicity in HepG2 cellsArchives of Toxicology, 2016
- Effects of usnic acid exposure on human hepatoblastoma HepG2 cells in cultureJournal of Applied Toxicology, 2011
- A review on usnic acid, an interesting natural compoundThe Science of Nature, 2002
- Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolationsToxicology and Applied Pharmacology, 1988